Suppr超能文献

肥胖型 ADAMTS-13 缺乏症小鼠中巨噬细胞耗竭对血栓性血小板减少性紫癜风险的血小板保护作用。

Platelet rescue by macrophage depletion in obese ADAMTS-13-deficient mice at risk of thrombotic thrombocytopenic purpura.

机构信息

Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium.

出版信息

J Thromb Haemost. 2018 Jan;16(1):150-163. doi: 10.1111/jth.13901. Epub 2017 Nov 28.

Abstract

UNLABELLED

Essentials Obesity is a potential risk factor for development of thrombotic thrombocytopenic purpura (TTP). Obese ADAMTS-13-deficient mice were triggered with von Willebrand factor (VWF). Depletion of hepatic and splenic macrophages protects against thrombocytopenia in this model. VWF enhances phagocytosis of platelets by macrophages, dose-dependently.

SUMMARY

Background Thrombotic thrombocytopenic purpura (TTP) is caused by the absence of ADAMTS-13 activity. Thrombocytopenia is presumably related to the formation of microthrombi rich in von Willebrand factor (VWF) and platelets. Obesity may be a risk factor for TTP; it is associated with abundance of macrophages that may phagocytose platelets. Objectives To evaluate the role of obesity and ADAMTS-13 deficiency in TTP, and to establish whether macrophages contribute to thrombocytopenia. Methods Lean or obese ADAMTS-13-deficient (Adamts-13 ) and wild-type (WT) mice were injected with 250 U kg of recombinant human VWF (rVWF), and TTP characteristics were evaluated 24 h later. In separate experiments, macrophages were depleted in the liver and spleen of lean and obese WT or Adamts-13 mice by injection of clodronate-liposomes, 48 h before injection of rVWF. Results Obese Adamts-13 mice had a lower platelet count than their lean counterparts, suggesting that they might be more susceptible to TTP development. Lean Adamts-13 mice triggered with a threshold dose of rVWF did not develop TTP, whereas typical TTP symptoms developed in obese Adamts-13 mice, including severe thrombocytopenia and higher lactate dehydrogenase (LDH) levels. Removal of hepatic and splenic macrophages by clodronate injection in obese Adamts-13 mice before treatment with rVWF preserved the platelet counts measured 24 h after the trigger. In vitro experiments with cultured macrophages confirmed a VWF dose-dependent increase of platelet phagocytosis. Conclusions Obese Adamts-13 mice are more susceptible to the induction of TTP-related thrombocytopenia than lean mice. Phagocytosis of platelets by macrophages contributes to thrombocytopenia after rVWF injection in this model.

摘要

未标注

肥胖是血栓性血小板减少性紫癜(TTP)发展的潜在危险因素。肥胖的 ADAMTS-13 缺乏症小鼠用血管性血友病因子(VWF)触发。肝和脾巨噬细胞耗竭可防止该模型中的血小板减少症。VWF 剂量依赖性地增强巨噬细胞对血小板的吞噬作用。

摘要

背景血栓性血小板减少性紫癜(TTP)是由 ADAMTS-13 活性缺失引起的。血小板减少症推测与富含血管性血友病因子(VWF)和血小板的微血栓形成有关。肥胖可能是 TTP 的一个危险因素;它与可能吞噬血小板的巨噬细胞的丰度有关。目的评估肥胖和 ADAMTS-13 缺乏症在 TTP 中的作用,并确定巨噬细胞是否有助于血小板减少症。方法将瘦或肥胖的 ADAMTS-13 缺陷(Adamts-13 )和野生型(WT)小鼠注射 250 U kg 重组人 VWF(rVWF),并在 24 小时后评估 TTP 特征。在单独的实验中,通过注射氯膦酸盐脂质体在瘦或肥胖的 WT 或 Adamts-13 小鼠的肝和脾中耗竭巨噬细胞,在注射 rVWF 前 48 小时。结果肥胖的 Adamts-13 小鼠的血小板计数低于其瘦对应物,表明它们可能更容易发生 TTP 发展。瘦的 Adamts-13 小鼠用阈值剂量的 rVWF 触发不会发展为 TTP,而肥胖的 Adamts-13 小鼠则出现典型的 TTP 症状,包括严重的血小板减少症和更高的乳酸脱氢酶(LDH)水平。在 rVWF 治疗前用氯膦酸盐注射清除肥胖的 Adamts-13 小鼠的肝和脾巨噬细胞可维持触发后 24 小时测量的血小板计数。与培养的巨噬细胞进行的体外实验证实了 VWF 剂量依赖性增加血小板吞噬作用。结论肥胖的 Adamts-13 小鼠比瘦小鼠更容易发生与 TTP 相关的血小板减少症。在该模型中,rVWF 注射后,巨噬细胞对血小板的吞噬作用导致血小板减少症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验